The selective T cell costimulation modulator abatacept can lead to a rapid improvement in proteinuria, which induces earlier, sustained complete response compared with placebo in patients with active class III or IV lupus nephritis, although the rate of complete response is similar between groups, suggests a study. |
Professionally managed pharmaceutical and health news website. Our news feed is from reliable sources on which we can depend on and spread forward for more awareness. Someone said "information is power" and we are here to use this information to further educate the mankind so that they can use this information to make a better-informed judgment. Wishing you all the best from www.genericmedicine.com
Friday, June 29, 2018
Abatacept may drive earlier, a sustained response in lupus nephritis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment